Hims ≠ Teladoc: Why Is HIMS Growing Much Faster Than TDOC Stock? Which Is Most Undervalued? скачать в хорошем качестве

Hims ≠ Teladoc: Why Is HIMS Growing Much Faster Than TDOC Stock? Which Is Most Undervalued?

#HIMS stock #TDOC stock #Teladocstock #Hims stock In this Hims and Teladoc stock video analysis, I explain why TDOC stock fell -25% today after a disappointing revenue growth outlook for the next 3 years following their Q4 of 2023 earnings. I still see HIMS as one of the most undervalued opportunities in the market right now, and as fundamentally undervalued. TDOC stock is also undervalued, and I see why it could appeal to a value investor, but their growth is slower than Hims because, in my view, health insurance slows them down. This is NOT INVESTMENT ADVICE! I realize that I am very bullish on Enphase. Let this video be simply a single datapoint in your own analysis of the stock and its potential. As always, this video is NOT investment advice, and none of the contents should be construed as such. I do not make short-term or long-term price predictions for any stock investment, and all words spoken in this video are for entertainment purposes ONLY .